United-Guardian, Inc.

UG

US9105711082

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:00:00 29/05/2024 am IST			5-day change	1st Jan Change
9.07 ^USD	+2.21%		-0.89%	+25.97%

15/05	Transcript : United-Guardian, Inc. - Shareholder/Analyst Call
10/05	Earnings Flash (UG) UNITED-GUARDIAN Reports Q1 Revenue $3.3M	MT

UNITED GUARDIAN INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

May 11, 2023 at 07:47 pm IST

Item 2.02. Results of Operations and Financial Condition.

On May 11, 2023, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

99.1 Press release dated May 11, 2023 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Latest news about United-Guardian, Inc.

Transcript : United-Guardian, Inc. - Shareholder/Analyst Call	15/05
Earnings Flash (UG) UNITED-GUARDIAN Reports Q1 Revenue $3.3M	11/05	MT
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 EPS $0.20	11/05	MT
United-Guardian, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	11/05	CI
United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
Global markets live: Meta, Amazon, Apple, Tesla, Intel...	02/02
United-Guardian Increases Dividend to $0.25 a Share, Payable Feb. 20 to Stockholders of Record Feb. 12; Shares up 5.1%	02/02	MT
United-Guardian, Inc. Declares Cash Dividend, Payable on February 20, 2024	02/02	CI
United-Guardian Appoints Catherine Joy Kolinski as Director	08/01	CI
Earnings Flash (UG) UNITED-GUARDIAN Posts Q3 Revenue $3.1M	06/11	MT
Earnings Flash (UG) UNITED-GUARDIAN Reports Q3 EPS $0.14	06/11	MT
United-Guardian, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11	CI
Earnings Flash (UG) UNITED-GUARDIAN Reports Q2 Revenue $2.7M	11/23/11	MT
United-Guardian, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
United-Guardian Declares Mid-Year Dividend, Payable on June 1, 2022	14/23/14	CI
United-Guardian, Inc. Declares Cash Dividend, Payable on August 2, 2023	14/23/14	CI
United-Guardian, Inc. Announces Resignation of Beatriz Blanco as Chief Executive Officer	14/23/14	CI
United-Guardian, Inc. Announces Beatriz Blanco Would Be Ending Her Employment as President of the Company	14/23/14	CI
United-Guardian, Inc. Appoints Donna Vigilante as President	14/23/14	CI
Transcript : United-Guardian, Inc. - Shareholder/Analyst Call	17/23/17
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 EPS $0.16	11/23/11	MT
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 Revenue $2.6M	11/23/11	MT
United-Guardian, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
United-Guardian, Inc. Declares Year-End Dividend, Payable on December 7, 2022	21/22/21	CI

United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
UNITED-GUARDIAN, INC.	+25.97%	41.67M
ELI LILLY AND COMPANY	+38.59%	727B
JOHNSON & JOHNSON	-7.89%	347B
MERCK & CO., INC.	+15.66%	319B
ABBVIE INC.	+0.24%	274B
ASTRAZENECA PLC	+12.98%	238B
NOVARTIS AG	+7.00%	204B
ROCHE HOLDING AG	-6.50%	203B
AMGEN INC.	+4.23%	161B
PFIZER, INC.	-1.70%	160B